Sanofi's SARS-CoV-2 spike protein (B.1.351 strain) vaccine, (VidPrevtyn Beta) is the first and only Beta variant protein-based COVID-19 booster approved in Great Britain and the European Union
Investegate announcements from Sanofi - Aventis Groupe, Press Release: Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission
Sanofi (SNY) and GSK s (GSK) next-generation COVID-19 booster vaccine VidPrevtyn® Beta approved by the European Commission streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Sanofi and GSK's next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission First and only next-generation protein-based adjuvanted COVID-19 booster approved